|
No. |
Topic |
Summary |
Pages |
9235
| The Role of EMEA in a changing Regulatory Environment | - | 74 |
9236
| Release Requirements: Blood, Biotech, APIs | - | 38 |
9237
| Expectations of the European authorities of the rle of the QPPV | - | 34 |
9238
| What does industry expect? - The EFPIA View | - | 28 |
9239
| What makes a good QP-Educational Requirements | - | 21 |
9240
| What makes a good QP: Skills and Competence | - | 6 |
9241
| The APIC view: The QP and GMP compliant APIs | - | 19 |
9242
| Dedicated Facilities | - | 20 |
9243
| Parallel Sessions 1:
Being an IMP QP in a global Envionment | - | 14 |
9244
| Parallel Session 2:
Import/Export | - | 33 |
9245
| Parallel Session 3:
Batch REleases | - | 24 |
9246
| Impact of Six Sigma for QPs | - | 16 |
9876
| ICH Q8, 9 and 10 - Impact and consequences for QPs | - | 39 |
9877
| Proposed revision of Annex 11 and Chater 4 | - | 38 |
